The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 38
Recomendaciones Sobre la Profilaxis Pre-Exposición para la Prevención de la Infección por VIH en España, 2023
Estas recomendaciones destacan el estado del VIH, el impacto potencial de la PrEP y la adherencia a la PrEP en España.
Rapid Assessment on Access to PrEP in EU/EEA Countries, 2022
This report clarifies the barriers to PrEP access in the EU/EEA countries, how they compare regionally, and what possible changes these countries can make to continue the fight against HIV.
Ukraine COP, 2021
The goal of the Ukraine’s 2021 Country Operational Plan is to maintain progress from 2020 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations in need.
HIV Pre-exposure Prophylaxis (PrEP) Knowledge among General Practitioners in 2020: A French survey
This article from Infectious Diseases Now analyses the knowledge of and position on PrEP amongst general practitioners in Hauts-de-France, France.
Cost-effectiveness Analysis of the Daily HIV Pre-exposure Prophylaxis in Men who Have Sex with Men in Barcelona
This article from PLOS One models the cost-effectiveness of daily oral PrEP use amongst gay and bisexual men who have sex with men in Barcelona, Spain.
Financing & Costing, Research
Rapid Assessment on Access to PrEP in EU/EEA Countries
This report by AIDS Action Europe summarizes the results of a survey of member organizations and partners based in EU Member States on various aspects of availability, accessibility, affordability, and acceptability of PrEP in their national context. In addition to the main findings, it includes country profiles and recommendations for the European Union and its…
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A descriptive study of the first 2 years’ experience
This article from Infectious Diseases and Therapy describes the results of a study of changes in PrEP users’ risk behaviors and sexually transmitted infections (STIs), as well as PrEP care continuum details, at a hospital-based PrEP program in Barcelona, Spain.
Research, Service Delivery
Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A review and synthesis of the literature
This review from the journal AIDS and Behavior provides an examination of the influences of the COVID-19 pandemic on engagement in the PrEP care continuum, and looks at the barriers and facilitators to PrEP uptake during this time.
Research, Service Delivery
Recommendations of the Swiss Federal Commission for Sexual Health (FCSH) on PrEP for HIV Prevention
In Switzerland, HIV drugs are not approved for prophylactic use. Physicians who prescribe oral chemoprophylaxis for HIV prevention do so on an off-label basis and are thus liable for any adverse effect that may occur. Nonetheless, the protective effects of oral PrEP are comparable to those of condom use, despite the higher price. The FCSH therefore…
Not PrEPared: Barriers to accessing HIV prevention drugs in England
In order to get a more comprehensive picture on what is happening with PrEP services across the UK, Terrence Higgins Trust, National AIDS Trust, PrEPster, Sophia Forum, and One Voice Network collected data from local authority sexual health commissioners, clinical staff, PrEP users, and those who sought to access PrEP. This report summarizes the findings,…